Hytrin and Left ventricular dysfunction - a phase IV clinical study of FDA data

Summary:

Left ventricular dysfunction is reported as a side effect among people who take Hytrin (terazosin hydrochloride), especially for people who are male, 60+ old, also take Zometa, and have Metastases to bone.

The phase IV clinical study analyzes which people have Left ventricular dysfunction when taking Hytrin. It is created by eHealthMe based on reports of 7,298 people who have side effects when taking Hytrin from the FDA, and is updated regularly.

What is Hytrin?

Hytrin has active ingredients of terazosin hydrochloride. It is often used in prostate examination abnormal. eHealthMe is studying from 7,501 Hytrin users. Check the latest studies of Hytrin.

What is Left ventricular dysfunction?

Left ventricular dysfunction is found to be associated with 892 drugs and 792 conditions by eHealthMe. Check the latest studies of Left ventricular dysfunction.

On Jul, 14, 2026

7,298 people reported to have side effects when taking Hytrin.
Among them, 26 people (0.36%) have Left ventricular dysfunction.

Could Hytrin cause Left ventricular dysfunction?

Among these 26 people:

What is the gender of people who have Left ventricular dysfunction when taking Hytrin? *

female: 11.54 %
male: 88.46 %

What is the age of people who have Left ventricular dysfunction when taking Hytrin? *

What are other drugs people take besides Hytrin? *

What are other side effects people have besides Left ventricular dysfunction? *

Pain: 23 people, 88.46%
Stress And Anxiety: 23 people, 88.46%
Fall: 22 people, 84.62%
Lung Infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung): 22 people, 84.62%
Spinal Osteoarthritis (joint cartilage loss in spine): 22 people, 84.62%
Osteonecrosis Of Jaw (death of bone of jaw): 21 people, 80.77%
Enlarged Heart: 21 people, 80.77%
Injury: 20 people, 76.92%
Renal Cyst (kidney cyst): 20 people, 76.92%
Pneumonia: 19 people, 73.08%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 11 people, 42.31%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 10 people, 38.46%
Osteoporosis (bones weak and more likely to break): 5 people, 19.23%
Bone Loss: 5 people, 19.23%
Prostate Cancer Metastatic: 5 people, 19.23%
Gastric Ulcer (stomach ulcer): 2 people, 7.69%
Chronic Lymphocytic Leukaemia Recurrent (repeated cancer of blood cells known as lymphocytes): 2 people, 7.69%
Pain: 2 people, 7.69%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 7.69%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Hytrin and have Left ventricular dysfunction?

- Check whether Left ventricular dysfunction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hytrin:

Hytrin (7,501 reports)

Browse all side effects of Hytrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Left ventricular dysfunction:

Left ventricular dysfunction (892 drugs)

Browse all the conditions that are associated with Left ventricular dysfunction:

Left ventricular dysfunction (792 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on terazosin hydrochloride (the active ingredients of Hytrin) and Hytrin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.